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Introduction: Studying primary adult microglia is hampered because of the difficult isolation procedure and the
low cell yield. We therefore established a differentiation protocol using a culture system developed for the
expansion of non-adherent bone marrow cells.
Methods: Non-adherent bone marrow derived stem cells (NA-BMC) are derived by selective adhesion (‘preplating’)
and are non adhesive adult stem cells. We investigated the changes in bone marrow cell populations by this
repeated selective adhesion and compared the potential of the derived cells to differentiate towards microglia. Cells
were differentiated with astrocyte conditioned medium (ACM) and granulocyte-monocyte colony stimulating factor
(GM-CSF).
Results: NA-BMC cultures show a steep raise in the fraction of stem cells during the cultivation time and the
differentiation potential is of the same quality as established protocols. Around 70% of the cells are microglia
defined as being positive for CD11b/CD45 and show phagocytosis activity and oxidative bursts.
Conclusion: The non-adherent cell system has the advantage that is produces stem cell progenitors during
expansion and provides good microglial differentiation.
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Microglia are the immune-cells of the brain. They react
to inflammatory signals, seek out and phagocytize debris,
promote repair and regeneration by excreting growth
factors [1]. Microglia might, however, promote neurode-
generative diseases like Alzheimer or multiple sclerosis
by dysregulation and overreaction to chronic inflamma-
tory signals. A suspected loss of their ability to function
as debris clearing cells with age or an insufficient re-
newal of their population in age was described [1]. The
role microglia play in these diseases and the possible
changes the microglia population undergoes with age are
the key to understand and combat the causes of
neurodegeneration.
Studies of microglia in vitro use mostly primary micro-
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distribution, and reproduction in any mediumdifficult to obtain and they are often derived from post-
mortem donors, posing some extra difficulties concern-
ing cell viability. To study the role of microglia in neuro-
degeneration it is however necessary to work with adult
material as the onset of the disease is age-dependent.
The alternative is to use blood or bone marrow derived
monocytes to derive microglia [2]. The in vitro gener-
ation of microglia may chart the way towards new thera-
peutic strategies using adult stem cells or to study the
function of microglia generated from individuals of all
ages and from diseased background to better understand
their role in neurodegeneration.
Non-adherent bone marrow cells (NA-BMCs) harbor
cells of the hematopoietic lineage [3]. NA-BMCs are known
to rescue lethally irradiated mice [3,4]. Their potential to
give rise to microglia could be of use in cell-based therapies
of the central nervous system (CNS) [1]. Non-adherent
mesenchymal stem cells (MSC) are present in NA-BMC
cultures as well [3]. They give rise to fibroblastic,entral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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have been found to colonize various tissues like bone mar-
row, spleen, intestine, kidney and liver.
NA-BMCs might correspond to a naturally circulating
population of cells [3], which carries progenitors of several
somatic cell types. In line with this, cells residing in the
blood have been differentiated to various cell types [5] and
it is known that peripheral blood monocytes can be differ-
entiated to microglia in vitro [6]. Also, fibroblast-like cells
are mobilized from the bone marrow by various effects like
cytokines, hypoxia and skin damage [7-10].
MSC are known to regulate microglia and other immune
cells [11-14]. Bone marrow derived mesenchymal stem cells
transplanted into the brain result in a reduction of amyl-
oid-ß plaques [15] - possibly by activation of resident
microglia to an amoeboid and phagocytic state. Trans-
planted MSC have positive effects in neurodegeneration by
regulation of the microenvironment and by cell fusion
[16,17]. MSC regulate activation of microglia in co-cultureFigure 1 (A) Overview showing the two differentiation methods. Repr
are shown. Day 0 – day 4: Phase of selective adhesion. Day 4 - day 10 an
per whole bone marrow on day 1 – day 4. Repeated selective adhesion res[18,19]. These findings suggest that inclusion of MSC in a
microglia cell population might even be beneficial.
To solve the problem of microglia availability and viabil-
ity we explore here the improved generation of microglia
cells from adult stem cells. We designed two new proto-
cols to differentiate microglia from so called non-adherent
bone marrow cells (NA-BMCs) (Figure 1), which can be
expanded efficiently in vitro in suspension cultures without
loss of stem cell properties. They correspond to a classical
method for macrophage differentiation (Protocol 2) and a
culture system originally developed for expansion of
stem cells (Protocol 1) (Figure 1). The different stages
and gradual changes during this expansion protocol
are poorly investigated. The composition of these cell
cultures over time, the changes in colony forming
units (CFU-f ) and the capacity to differentiate to
microglia have not been characterized in the past. Spe-
cial focus was on the functional characterization of the
microglia derived by this protocol.esentative forward scatter (FSC) and side scatter (SSC) plots of NA-BMC
d day 1 - day 7: Differentiation phase. (B) Yield of non-adherent cells
ults in a falling number of cells.
Figure 2 (A) Scatter plots of NA-BMC during the selective adhesion phase. The indicated regions define populations of immature and
nucleated red blood cells, lymphocytes, monocytes and granulocytes. P is the probability of the null hypothesis of the linear regression, i. e. that
the percentage fraction does not change over time. (B) Changes in the percentage fraction of the cell populations is shown. Lymphocyte fraction
is diminished by selective adhesion. (C) CFU-f grown from NA-BMCs of day 1 to day 4 (n=3). Methylene blue staining was used to determine total
colonies. Alizarin red (Calcium), Sirius red (Collagen) and alkaline phosphatase (ALP) staining were used to detect the capacity of NA-BMC for
osteogenic differentiation.
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Animals
Animals used for the experiments were C57BL/6 from
the MEZ Leipzig and Charles River (Sulzfeld, Germany).
They were handled in accordance to local animal ethics
regulations.
Bone marrow isolation and culture of NA-BMC
Femurae and tibiae of 2–3 month old C57BL/6 mice were
isolated, opened and centrifuged to obtain bone marrow.
107 bone marrow cells were cultivated for 24 h in a 60 mm
petri dish and in 10 ml Dulbecco’s modified eagle medium
(low glucose) (DMEM, Hyclone Laboratories Inc.), supple-
mented with 10% fetal calf serum (FCS) (Invitrogen),
10-8M dexamethasone and 100 units/ml Penicillin/
Streptomycin (Invitrogen). After 24 h the non-adherent
cells were flushed off and transferred to a new dish (proto-
col 2; Figure 1). This 24 h adhesion period was repeated 4
times to derive NA-BMC cells (protocol 1; Figure 1).CFU-f
The non-adherent cells of day 1 (classical replating proto-
col to derive macrophages, protocol 2) and NA-BMCs
from day 4 (protocol 1) were resuspended in 5 ml osteo-
genic medium (DMEM, 10% FCS, 10-8 M dexamethasone,
50 μg/ml ascorbic acid) in a 60 mm dish. Every 3 days, the
medium was changed. After 10 days, the cells were fixed
with cold ethanol and alkaline phosphatase (ALP), calcium
(Alizarin red), collagen (Sirius red) and methylene blue
(total colonies) staining performed. The colony numbers
were determined using the program ImageJ.
ALP staining
The cells in 60 mm petri dishes were fixed with cold
ethanol for 15 min. They were washed with tap water.
Tris (200 mM, pH 8.5) was mixed with naphthol phos-
phate ASBI (50 μg/ml) and fast red (1 mg/ml) (Fast red
was always mixed fresh). 5 ml of the mixture was added
to petri dishes. The dishes were shaken for 2 h at room
Figure 3 Median of NA-BMC antigen expression during day 0 – day 4 of selective adhesion. Both markers of differentiated (F4/80) and
undifferentiated hematopoietic cells (CD34) rise. Cell size gets smaller, larger cells seem to become adherent. The regression tests for a statistically
significant change over time. P is the probability of the null hypothesis – that marker expression does not change over time.
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water and allowed to dry. Photographs of the dishes
were taken and colony numbers determined with
ImageJ.
Alizarin red staining (Calcium)
Cells were fixed for 15 min with ice-cold ethanol, after-
wards washed with tap water. 5 ml of a solution of 1 mg/
ml alizarin red in distilled water, pH 5.5 were added. The
petri dishes were shaken for 2 h, afterwards washed with
tap water and allowed to dry. Images were analyzed for cal-
cium amount using ImageJ.
Sirius red staining (Collagen)
Cells were fixed in ice-cold ethanol for 15 min and washed
with tap water. 1 mg/ml sirius red was solved in picric acid.
5 ml of the mixture was added to the cells and the petri
dishes shaken for 18 h at room temperature. Then the cells
were washed with tap water till red color was completelyeluted. The dishes were photographed and analyzed for the
amount of collagen (ImageJ).
Methylene blue staining (total colony numbers)
Cells were fixed in ice-cold ethanol for 15 min. They were
washed in tap water. 1 mg/ml methylene blue was solved in
10 mM borate buffer, pH 8.8. 5 ml of the mixture was
added to the petri dishes and shaken for 30 min. The dishes
were washed with tap water until all dye was eluted, photo-
graphed and analyzed using ImageJ.
Astrocyte conditioned medium
Astrocyte conditioned medium was produced by incu-
bating medium (DMEM/10% FCS) 24 h with primary
astrocyte cultures produced as described by Sievers [2].
Differentiation towards microglia-like cells
On day 1 (protocol 2) and day 4 (protocol 1), the non-
adherent cells were flushed off and transferred to a new
Figure 4 (A) Representative scatter plots of differentiated cells. A microglia gate was set, defined by the primary microglia population, to
assess differentiation. (B) Percent of CD11b/CD45low (microglia gate) among the differentiated cells (n=3). Yields of cells showing the microglia
markers are not different between the two protocols. A small subpopulation in fresh bone marrow (10%) shows microglia markers from the
beginning. (C) and (D) Percent of CD11b+ and CD45+ cells among the differentiated cells (n=3). CD45 is already high in fresh bone marrow. P1:
Protocol 1. P2: Protocol 2. *** = P< 0.001, ** = P< 0.005, * = P< 0.01.
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10 ml DMEM/10% FCS, 50% ACM and 20 ng/ml gran-
ulocyte-monocyte colony stimulating factor (GM-CSF).
Controls were cultured only in DMEM/10% FCS.
Flow cytometry
Cell were stained for F4/80 (AF488 labelled, eBioscience)
(1:250), CD11b/CD45 (AF488 and PE labelled eBioscience)
(1:250 and 1:100) and CD34 (PE labelled, Caltag Labora-
tories) (1:100), CD45 R (RPE labelled, Southern Biotech)
(1:100). Cells were trypsinized, centrifuged (300 g for
5 min) and fixed (4% paraformaldehyd). The fixed cells
were washed with PBS, incubated for 2 h at 4°C with pri-
mary antibody, washed and analysed in a Beckmann
Coulter FC 500 Flow cytometer.
Phagocytosis
3*105 cells were activated with 0.1 μM phorbol myristic
acid for 15 min. Then they were incubated in 50 μlDMEM/10% FCS together with 50 μl 1:10 diluted opso-
nised beads (2.25*107 beads) (Sigma) for 48 h at 37°C,
5% CO2. Cells were trypsinized and resuspended in
DPBS (Invitrogen) and fluorescence was measured in a
Beckmann Coulter FC 500.
Oxidative burst
3*105 cells were activated for 15 min with 0.1 μM PMA
and controls without PMA. Activated and control cells
were incubated with 50 μM DHR123 for additional
15 min. Afterwards the cells were fixed with 4% PFA and
fluorescence was measured in a Beckmann Coulter FC
500. Oxidative burst was defined as signal to noise ratio
(The ratio of fluorescence of activated to control cells).
Living brain slice cultures
Brains from 2–3 month old C57BL/6 mice were trans-
ferred to cold Hank’s buffered salt solution (HBSS)/10%
FCS (both Invitrogen). A VT 1000 S vibratome (Leica) was
Figure 5 (A) Representative histogram plots of F4/80 expression. Gray line is the isotype control. (B) Percent of F4/80+ cells among the
differentiated cells (n=3). Protocol 2 shows higher F4/80 expression than protocol 1 although, during selective adhesion, F4/80 rose steadily. P1:
Protocol 1. P2: Protocol 2. *** = P< 0.001, ** = P< 0.005, * = P< 0.01.
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ture on a membrane (Millicell CM 0.4 μm, Millipore) at
the liquid air interface of medium consisting of 50%
DMEM/high glucose (HyClone Laboratories Inc.), 25%
horse serum (Invitrogen), 25% HBSS (Invitrogen), 1 μg/ml
insulin (Invitrogen), 100units/ml penicillin and 100 μg/ml
streptomycin (Invitrogen). The brain slices were cultured
for 9 days and the viability of the brain slices was assessed
using DAPI/propidium iodide staining. For analysis the
slices were scanned using a confocal microscope (TCS
SP2, Leica Microsystems).
Invasion of living brain tissue
On day 9 of brain slice culture, differentiated cells were
treated with DIO (Invitrogen) for 20 min, washed and
seeded on the top of the brain slices. A plastic ring was
used to keep the cells from flowing off the slices. Cells
and brain tissue were co-cultivated for additional 10 days
[20]. After 10 days migration of cells into brain tissue
was measured by scanning the slices with a confocal
microscope (TCS SP2, Leica Microsystems) to a depth of
160 μm.
Statistical analysis
Data is presented as means ± SE. SigmaPlot 10.0/Sigma-
Stat 3.5 software (SYSTAT, Erkrath, Germany) was used
to perform statistical analysis. For comparison of differ-
ent groups ANOVA was used.
Results
Cell populations during selective adhesion and
differentiation
The numbers of non-adherent cells in culture fell swiftly
from day 0 to day 4 of selective adhesion (Figure 1B).
From whole bone marrow, after 1 day of selective adhe-
sion 3.5*106 non-adherent cells remained. After 4 days of
selective adhesion cell yield was 1.7*106 non-adherent
cells.The NA-BMC cultures were analysed at different days
using flow cytometry (Figure 2A). The prominent cell
populations – of immature/nucleated red blood cells,
lymphocytes, monocytes and granulocytes – were
defined according to their forward and side scattering
(Figure 2A) as done by other groups [21]. The fraction of
these populations changed during selective adhesion
(Figure 2B). The fraction of lymphocytes decreased sig-
nificantly from 35.6% to 10.7% during the 4 transfers of
non-adherent cells (P< 0.05). The population of imma-
ture and nucleated red blood cells (NRBC) increased
from 28.2% to 50.8% (P= 0.13). Monocyte and granulo-
cyte populations did not change during the cultivation
(Figure 2B). The cells derived using protocol 2 still had a
prominent lymphocyte population while the cells from
protocol 1 lacked lymphocytes (Figure 2A and B). The
supernatant of each day was used for colony forming
unit (CFU-f) assays. The frequency of methylene blue
positive colonies doubled (P< 0.05), alkaline phosphatase
(ALP) and calcium positive colonies tripled (P< 0.01),
while collagen positive colonies did not change signifi-
cantly (Figure 2C).
Marker expression levels
As this technique was not used before for the derivation
of microglia, we wanted to describe the cultures in
some detail and the changes occurring over time. Dur-
ing the selective adhesion period, using protocol 1, cell
granularity doubled and the mean cell size decreased 3
fold (Figure 3). We were especially interested in the fre-
quency of cells expressing macrophages/microglia markers
and hematopoietic progenitor markers. The median of
CD34 expression tripled significantly (P< 0.05), as well as
4-fold CD45 R expression (P< 0.05) and doubled F4/80
expression (P< 0.05). No change of CD45 expression was
observed. CD11b expression decreased, significantly, 3-fold
(P< 0.05) during the 4 days of selective adhesion
(Figure 3).
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The selection of non-adherent cells by adhesion was com-
bined with differentiation media. Our new cell culture
protocol (protocol 1) was compared with the classical ap-
proach (protocol 2).
It is difficult to differentiate between macrophages
and activated microglia. We used a combination of
non-exclusive markers and typical morphology (ram-
ification) as specific signs of microglia (resting macro-
phages) as suggested by [22]. In addition we used the
combination of CD11b/CD45 expression as employed
by other groups [22,23] and the macrophage marker
F4/80.Figure 6 (A) Phagocytic activity of differentiated cells. Cells of the class
fluorescent beads. Cells un-supplemented with ACM and GM-CSF show low
not different between protocol 1 and protocol 2. P1: Protocol 1. P2: Protoc
contain many non-adherent cells. Morphologies and resulting cell types are
(G-J) Most differentiated cells survive in co-culture and remain largely amo
with living brain slices. Top down and side view pictures. Differentiated cel
slices. Dead cells were labeled red (propidium iodide). After 10 days of co-c
the brain slices to a depth of 160 μm (Magnification 100x). (H, J) Cells of th
60 μm. *** = P< 0.001, ** = P< 0.005, * = P< 0.01.The cells derived using protocol 1 and 2 were differen-
tiated to microglia with astrocyte conditioned medium
(ACM) and granulocyte-monocyte colony stimulating fac-
tor (GM-CSF) supplementation for 6 days. The cells differ-
entiated using protocol 1 were as efficient producing
microglia-like cells as protocol 2 – judged by the marker
combinations suggested to be specific for microglia (Figure 4
and Figure 5).
Functional tests
Microglia derived using protocol 2 showed a significantly
higher phagocytosis rate (1/4 higher) than the cells from
protocol 1 (Figure 6A). Supplementation of ACM andical pre-plating protocol 2 show significantly higher phagocytosis of
phagocytosis. (n = 3). (B) Oxidative burst of the differentiated cells is
ol 2. (n = 3). (C-F) Differentiated cells of protocol 1 are smaller and
diverse. Images were taken with a Leica DMIL at 200x magnification.
eboid and round, typical for activated states. The cells were co-cultured
ls were labeled green (DIO) and transferred onto 9 day old living brain
ulture a Leica Microsystems SP2 confocal microscope was used to scan
e cytokine supplemented cultures invade surface up to a depth of
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phagocytic ability of the differentiated cells in both pro-
tocols. It is interesting to notice that cells of both ACM/
GM-CSF supplemented and unsupplemented cultures
show almost the same marker expression (Figure 4BCD,
Figure 5B) but differ in phagocytosis (Figure 6A).
Microglia from cultures of protocol 1 showed the same
capacity for an oxidative burst as microglia derived from
protocol 2 cultures (Figure 6B). Cytokine supplementa-
tion significantly increased oxidative burst in cells
derived using protocol 2 - that was present both in supple-
mented and unsupplemented microglia from protocol 1.
Morphology
Cells derived from protocol 1 show many small and non-
adherent cells and all differentiated cell populations
show mixed morphologies as is typical for microglia cul-
tures (Figure 6C-F). Extensive ramification was, however,
not visible.
Organotypical brain slices
The cells differentiated with protocol 2 invaded living
brain tissue to a depth of up to 80 μm (Figure 6J). Most
of the cytokine differentiated cells and the un-supple-
mented cells migrated into the surface of the slices to a
depth of 30 μm.
Cells differentiated from classical derived macrophage
showed amoeboid morphology (Figure 6I, J). Cells differ-
entiated from NA-BMCs showed round morphologies
(Figure 6G, H). In our qualitative migration experiments
cells treated with ACM/GM-CSF or cells derived by
protocol 2 migrated deepest (Figure 6J).
Discussion
Microglia derived from adult material are difficult to ob-
tain. Most studies have been performed on microglia
from neonatal sources and cell yields from adult sources
are low. In settings where cells would be used clinically,
autologous sources are preferable. Bone marrow cells are
routinely used for transplantation and contain different
stem cell types. We have established here a protocol for
the derivation of functional microglia using adult bone
marrow providing a source for cell therapy or drug de-
velopment. It is assumed that in the healthy brain micro-
glia are replenished locally but that under pathological
conditions and inflammation bone marrow derived cells
can invade the brain and differentiate to microglia [24].
We used a stem cell cultivation method which was ori-
ginally developed to expand the undifferentiated stem
cell population [3,25] and tested their use as source for
microglia. Repeated selective adhesion, as employed to
derive non-adherent bone marrow cells (NA-BMCs), re-
sult in a rising capacity of NA-BMCs to form CFU-f.
This as well as the high CD34 expression shows that thefrequency of stem cells or progenitors increases during
time in these cultures. The lymphocyte population in the
new suspension cultures (protocol 1) gets diminished by
the repeated adhesion and the fraction of immature cells
increases. This corresponds to results from other groups
showing in rats the increase of CFU-f initiating cells dur-
ing the repeated re-plating steps [3]. The results for the
monocyte lineage were mixed and we can not conclude
whether, during the initial culture phase the numbers of
progenitors for microglia are diminished or not.Microglia differentiation
No single marker distinguishes microglia from macro-
phages. Some publications suggest that CD45 and
CD11b together might distinguish between microglia
and macrophages [26]. CD45 is a marker for the
hematopoietic cells and F4/80 for microglia and macro-
phages [27]. Our new protocol using non-adherent bone
marrow cells showed the same level of differentiation to-
wards microglial cells as protocol 2, based on the clas-
sical macrophage differentiation - judged by expression
of CD11b+/CD45low and F4/80+, which, together with
morphology (ramification), define the microglia popula-
tion as described by previous studies [22,23]. Functional
microglia derived using the new protocol 1 showed
slightly less phagocytosis activity than those of protocol 2,
but the burst activity was of the same level.
The lower phagocytosis of cells from protocol 1 might
be due to less differentiated and more primitive cells in
the supernatant of day 4. It might also be an effect of the
longer time in culture before differentiation. That phago-
cytosis is low in absence of cytokine supplementation is
known [28]. Oxidative burst of the differentiated cells is
not significantly higher than that of whole bone marrow.
Although there are subpopulations in whole bone mar-
row that do show strong oxidative burst this might point
to an immature microglia cell type [29].
Morphologies were mixed and only few cells showed
clearly branches typical for primary resting microglia as
one would expect when cells were incubated with astro-
cyte conditioned medium. The amoeboid and round cell
morphology in the co-culture with brain slices indicates
an active state in all tested protocols. This might be
induced by the apoptotic cells in the slice. It is known
that microglia of the brain slices migrate to the surface
and phagocytize debris there [30].Conclusions
Repeated selective adhesion enriches for stem cells and
provides great numbers of microglia, which are function-
ally active. This protocol provides functional adult
microglia which can be used for drug development or
cell therapies.
Hinze and Stolzing Journal of Inflammation 2012, 9:12 Page 9 of 9
http://www.journal-inflammation.com/content/9/1/12Competing interests
The authors declare that they have no competing interests.
Acknowledgments
I want to thank for help with confocal microscopy by Prof. Dr. Käs and
Undine Dietrich of the Biophysics Group University Leipzig and for help with
brain slice cultures by Prof. Dr. Seeger and Gabriele Lindner, Veterinary
Anatomy University Leipzig. I thank Moath al Mekhlafi for help with the cell
phenotyping.
Authors’ contributions
AH carried out all experiments and wrote the manuscript. AS designed &
coordinated the study and contributed to writing the manuscript. All authors
read and approved the final manuscript.
Received: 24 August 2011 Accepted: 2 April 2012
Published: 2 April 2012
References
1. Streit WJ: Microglial senescence: does the brain's immune system have
an expiration date? Trends Neurosci 2006, 29:506–510.
2. Sievers J, Parwaresch R, Wottge HU: Blood monocytes and spleen
macrophages differentiate into microglia-like cells on monolayers of
astrocytes: morphology. Glia 1994, 12:245–258.
3. Zhang ZL, Tong J, Lu RN, Scutt AM, Goltzman D, Miao DS: Therapeutic
potential of non-adherent BM-derived mesenchymal stem cells in tissue
regeneration. Bone Marrow Transplant 2009, 43:69–81.
4. Fricke S, Fricke C, Oelkrug C, Hilger N, Schonfelder U, Kamprad M, Lehmann
J, Boltze J, Emmrich F, Sack U: Characterization of murine non-adherent
bone marrow cells leading to recovery of endogenous hematopoiesis.
Cell Mol Life Sci 2010, 67:4095–4106.
5. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG:
Circulating skeletal stem cells. J Cell Biol 2001, 153:1133–1140.
6. Leone C, Le Pavec G, Meme W, Porcheray F, Samah B, Dormont D, Gras G:
Characterization of human monocyte-derived microglia-like cells. Glia
2006, 54:183–192.
7. Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, Gorodetsky R:
Isolation of mesenchymal stem cells from G-CSF-mobilized human
peripheral blood using fibrin microbeads. Bone Marrow Transplant 2006,
37:967–976.
8. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M,
Isner JM, Asahara T: Ischemia- and cytokine-induced mobilization of bone
marrow-derived endothelial progenitor cells for neovascularization. Nat
Med 1999, 5:434–438.
9. Rochefort GY, Delorme B, Lopez A, Herault O, Bonnet P, Charbord P, Eder V,
Domenech J: Multipotential mesenchymal stem cells are mobilized into
peripheral blood by hypoxia. Stem Cells 2006, 24:2202–2208.
10. Mansilla E, Marin GH, Drago H, Sturla F, Salas E, Gardiner C, Bossi S,
Lamonega R, Guzman A, Nunez A, et al: Bloodstream cells phenotypically
identical to human mesenchymal bone marrow stem cells circulate in
large amounts under the influence of acute large skin damage: new
evidence for their use in regenerative medicine. Transplant Proc 2006,
38:967–969.
11. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, Jorgensen
C: Immunosuppressive effect of mesenchymal stem cells favors tumor
growth in allogeneic animals. Blood 2003, 102:3837–3844.
12. Stagg J: Immune regulation by mesenchymal stem cells: two sides to the
coin. Tissue Antigens 2007, 69:1–9.
13. Kim J, Hematti P: Mesenchymal stem cell-educated macrophages: a novel
type of alternatively activated macrophages. Exp Hematol 2009, 37:1445–
1453.
14. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, Nepomnaschy I,
Costa H, Canones C, Raiden S, Vermeulen M, Geffner JR: Mouse bone
marrow-derived mesenchymal stromal cells turn activated macrophages
into a regulatory-like profile. PLoS One 2010, 5:e9252.
15. Lee JK, Jin HK, Bae JS: Bone marrow-derived mesenchymal stem cells
reduce brain amyloid-beta deposition and accelerate the activation of
microglia in an acutely induced Alzheimer's disease mouse model.
Neurosci Lett 2009, 450:136–141.
16. Bae JS, Furuya S, Ahn SJ, Yi SJ, Hirabayashi Y, Jin HK: Neuroglial activation
in Niemann-Pick Type C mice is suppressed by intracerebraltransplantation of bone marrow-derived mesenchymal stem cells.
Neurosci Lett 2005, 381:234–236.
17. Bae JS, Han HS, Youn DH, Carter JE, Modo M, Schuchman EH, Jin HK: Bone
marrow-derived mesenchymal stem cells promote neuronal networks
with functional synaptic transmission after transplantation into mice
with neurodegeneration. Stem Cells 2007, 25:1307–1316.
18. Ooi YY, Ramasamy R, Rahmat Z, Subramaiam H, Tan SW, Abdullah M, Israf
DA, Vidyadaran S: Bone marrow-derived mesenchymal stem cells
modulate BV2 microglia responses to lipopolysaccharide. Int
Immunopharmacol 2010, 10:1532–1540.
19. Zhou C, Zhang C, Chi S, Xu Y, Teng J, Wang H, Song Y, Zhao R: Effects of
human marrow stromal cells on activation of microglial cells and
production of inflammatory factors induced by lipopolysaccharide. Brain
Res 2009, 1269:23–30.
20. Stoppini L, Buchs PA, Muller D: A simple method for organotypic cultures
of nervous tissue. J Neurosci Methods 1991, 37:173–182.
21. Salzman GC, Crowell JM, Martin JC, Trujillo TT, Romero A, Mullaney PF,
LaBauve PM: Cell classification by laser light scattering: identification and
separation of unstained leukocytes. Acta Cytol 1975, 19:374–377.
22. Servet-Delprat C, Arnaud S, Jurdic P, Nataf S, Grasset MF, Soulas C,
Domenget C, Destaing O, Rivollier A, Perret M, et al: Flt3+ macrophage
precursors commit sequentially to osteoclasts, dendritic cells and
microglia. BMC Immunol 2002, 3:15.
23. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD: Normal adult ramified
microglia separated from other central nervous system macrophages by
flow cytometric sorting. Phenotypic differences defined and direct
ex vivo antigen presentation to myelin basic protein-reactive CD4+ T
cells compared. J Immunol 1995, 154:4309–4321.
24. Simard AR, Rivest S: Neuroprotective effects of resident microglia
following acute brain injury. J Comp Neurol 2007, 504:716–729.
25. Fricke S, Ackermann M, Stolzing A, Schimmelpfennig C, Hilger N, Jahns J,
Hildebrandt G, Emmrich F, Ruschpler P, Posel C, et al: Allogeneic non-
adherent bone marrow cells facilitate hematopoietic recovery but do not
lead to allogeneic engraftment. PLoS One 2009, 4:e6157.
26. Stoll G, Jander S: The role of microglia and macrophages in the
pathophysiology of the CNS. Prog Neurobiol 1999, 58:233–247.
27. Austyn JM, Gordon S: F4/80, a monoclonal antibody directed specifically
against the mouse macrophage. Eur J Immunol 1981, 11:805–815.
28. Naito M: Macrophage heterogeneity in development and differentiation.
Arch Histol Cytol 1993, 56:331–351.
29. Santambrogio L, Belyanskaya SL, Fischer FR, Cipriani B, Brosnan CF, Ricciardi-
Castagnoli P, Stern LJ, Strominger JL, Riese R: Developmental plasticity of
CNS microglia. Proc Natl Acad Sci U S A 2001, 98:6295–6300.
30. Heppner FL, Skutella T, Hailer NP, Haas D, Nitsch R: Activated microglial
cells migrate towards sites of excitotoxic neuronal injury inside
organotypic hippocampal slice cultures. Eur J Neurosci 1998, 10:3284–3290.
doi:1476-9255-9-12
Cite this article as: Hinze and Stolzing: Microglia differentiation using a
culture system for the expansion of mice non-adherent bone marrow
stem cells. Journal of Inflammation 2012 9:12.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
